Notwithstanding significant controversy about methods and fairness, the Centers for Medicare and Medicaid Services keeps rolling right along with its hospital readmissions program. A Kaiser Family Foundation brief looks at the results as the second year ends. (Kaiser Brief) For the second year, $227 million in penalties will be applied to payments to 2225 hospitals that have “excess” readmissions, at least according to CMS. Eighteen hospitals will get the maximum 2% reduction in payments for the next year and another 154 will lose over 1% of payments. The total amount of penalties is down $53 million from the first year and about 1370 hospitals lowered their penalty from the first year, so that might be a sign of improvement. On the other hand, 1074 hospitals are getting increased penalties. The number going up and down suggests a lot of pure regression to the mean, which has nothing to do with performance and everything to do with statistical randomness. In some states, like Alabama, Arkansas, Florida, Kentucky, Illinois, Massachusetts, New York, New Jersey and Tennessee, about 80% of the hospitals are being penalized, which suggests something at work regarding the health status of the population in those states. While CMS changed some aspects of the formula, like the obvious one of omitting planned readmissions, the program still hits hospitals treating poor people the hardest and those are likely the hospitals that can least afford to lose revenue. While many hospital readmissions are likely avoidable, the CMS formula does a very poor job of identifying these and as the penalty ratchets up to 3% next year, CMS needs to give a hard rethink to whether it is achieving the goal of improving quality or is just nailing hospitals for something they have little control over.
Current Status of CMS Hospital Readmission Penalty Program
By Kevin RocheAugust 7, 2013Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
In an attempt to swiftly revive two floundering health care companies, a PE firm has announced the merger and recapitalization of Revive Health and SwiftMD. You know they are...
January 30, 2023
Investors have not yet learned their lesson, as Pearl Health gathers a new round of $75 million in capital for its business of supporting physicians who want to participate in...
January 30, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
March 27, 2023
Why You Can’t Trust People Who Make Up Stuff About Vax Safety
A couple of studies offer a far better explanation for heart issues in athletes and…
March 25, 2023
Coronamonomania Lives Forever, Part 201
Tired of March Madness? A boringly refreshing dip into some CV-19 research summaries is recommended.
March 24, 2023
The CDC Is a Font of Methodological and Statistical Error
Several times in the last three years I and others have pointed out serious flaws…